跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,491 条关于
“Torii Pharmaceutical”
全部
13,491
临床试验
790
药物
1,662
机构
2,159
资讯
8,880
去年
Shionogi Receives Regulatory Clearance for Torii Pharmaceutical Acquisition, Tender Offer Proceeds
去年
Torii Pharmaceutical Submits NDA in Japan for Verrica's Molluscum Contagiosum Treatment, TO-208
前天
Shionogi and Torii Win Japanese Approval for VTAMA Cream 0.5% in Pediatric Atopic Dermatitis
去年
Shionogi to Acquire Japan Tobacco's Pharma Units for $1.1 Billion
去年
Shionogi to Acquire Japan Tobacco's Pharmaceutical Subsidiaries for $1.1 Billion
上个月
Japan Approves VTAMA Cream 0.5% for Atopic Dermatitis in Children Under 12
2个月前
Verrica Doses First U.S. and Japanese Patients in Phase 3 COVE-3 Trial of YCANTH for Common Warts
去年
Verrica Pharmaceuticals Launches Global Phase 3 Trial for YCANTH in Common Warts, Targeting 22 Million US Patients
8个月前
Verrica Pharmaceuticals Initiates Phase 3 Trial for VP-102 in Common Warts Treatment
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
第 1 页,共 888 页
上一页
下一页